Business
One2One Investor Forum
One2One Investor Forum.
About this update from Iconic Labs Plc
[{"type":"text","content":"\n \nRNS Number : 5137T WideCells Group PLC 21 March 2019 \n\nWideCells Group PLC ('WideCells' or 'the Company)\nProactive Investors One2One Investor Forum Presentation \n \nWideCells is pleased to announce that following the creation of Iconic Labs, a new media and technology business focussed on providing online marketing, content and technology driven products (as announced 18 March 2019), its Chief Executive Officer, John Quinlan, will be presenting at Proactive Investors One2One Investor Forum at 6pm this evening (Thursday 21 March 2019). The presentation will provide an overview of Iconic Labs and its strategy going forward.\n \nThe Investor Forum will be held at Chesterfield Mayfair Hotel, 35 Charles Street, London, W1J 5EB. For more information and to register attendance for the event, please visit: https://www.proactiveinvestors.co.uk/register/event_details/193. \n \n**ENDS**\n \nFor further information, please visit the Company's website www.iconiclabs.co.uk or contact:\n \n\n\n\nShard Capital Partners LLP\n\n\nJoint Broker - Damon Heath & Erik Woolgar \n\n\nTel: +44 (0) 20 7186 9950\n\n\n\n\nfinnCap Ltd \n\n\nJoint Broker - Christopher Raggett \n\n\nTel: +44 (0) 20 7220 0500\n\n\n\n\nSt Brides Partners Limited\n\n\nPR - Melissa Hancock & Juliet Earl\n\n\nTel: +44 (0) 20 7236 1177\n\n\n\n \n \n \n \n \n \n \n\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com. END NRACKKDPDBKBPNB\n ","length":3966,"tagName":"div"}]